In the published article, there was an error in the affiliations list for author Jing Jiang. Instead of “Department of Spine Surgery, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China”, it should be “Department of Clinical Laboratory, Nanchang Medical College, Nanchang, China”.
In the published article, there was an error in the affiliations list for author Quanhe Qiu. Instead of “Department of Orthopedic, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huaian, China”, it should be “Department of Spine Surgery, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China”.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
osteosarcoma, scRNA-seq, tumor microenvironment, metastasis, recurrent, nuclear receptor
Citation
Liu W, Hao Y, Tian X, Jiang J and Qiu Q (2022) Corrigendum: The role of NR4A1 in the pathophysiology of osteosarcoma: A comprehensive bioinformatics analysis of the single-cell RNA sequencing dataset. Front. Oncol. 12:1027056. doi: 10.3389/fonc.2022.1027056
Received
24 August 2022
Accepted
26 August 2022
Published
13 September 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Liu, Hao, Tian, Jiang and Qiu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Quanhe Qiu, qiuheima@163.com; Jing Jiang, jiangjing612@163.com
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.